Heme oxygenase-1 inhibits angiotensin II-induced cardiac hypertrophy in vitro and in vivo

Circulation

Volumn 110, Issue 3, 2004, Pages 309-316

  Hu, Chien Ming ^a   Chen, Yen Hui ^a   Chiang, Ming Tsai ^a   Chau, Lee Young ^a  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

Angiotensin; Heme oxygenase; Hypertrophy

Indexed keywords

ANGIOTENSIN; BILIRUBIN; COBALT; DICHLOROFLUORESCEIN; HEME OXYGENASE 1; HEME OXYGENASE INHIBITOR; PORPHYRIN COBALT; PROTOPORPHYRIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ADENOVIRUS; AMINO ACID TRANSPORT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL SIZE; CONTROLLED STUDY; ENZYME INHIBITION; GENE; GENE OVEREXPRESSION; HEART CONTRACTION; HEART HYPERTROPHY; HEART PROTECTION; HEART VENTRICLE REMODELING; HO 1 GENE; IN VITRO STUDY; IN VIVO STUDY; MALE; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DEGRADATION; RAT; VIRUS RECOMBINANT;

ANGIOTENSIN II; ANIMALS; BILIRUBIN; CARDIOMEGALY; HEME OXYGENASE (DECYCLIZING); HEME OXYGENASE-1; MALE; MYOCYTES, CARDIAC; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES;

EID: 3242661655     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000135475.35758.23     Document Type: Article

References (34)

1. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev. 1999;79:215-262.
2. Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev. 2000;52:11-34.
3. Sadoshima J, Xu J, Slayter HS, et al. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 1993;75:977-984.
4. Leri A, Claudio PP, Li Q, et al. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decrease the Bcl-2 to Bax protein ratio in the cell. J Clin Invest. 1998;101:1326-1342.
5. Otterbein LE, Choi AMK. Heme oxygenase: colors of defense against cellular stress. Am J Physiol. 2000;279:L1029-L1037.
6. Yet S-F, Perrella MA, Layne MD, et al. Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice. J Clin Invest. 1999;103:R23-R29.
7. Yoshida T, Maulik N, Ho YS, et al. H(mox-1) constitutes an adaptive response to effect antioxidant cardioprotection: a study with transgenic mice heterozygous for targeted disruption of the heme oxygenase-1 gene. Circulation. 2001;103:1695-1701.
8. Clark JE, Foresti R, Sarathchandra P, et al. Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. Am J Physiol Heart Circ Physiol. 2000;278:H643-H651.
9. Yet S-F, Tian R, Layne MD, et al. Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice. Circ Res. 2001;89:168-173.
10. Vwlapalli SR, Chen SR, Chua Z, et al. Cardioselective overexpression of HO-1prevents 1/R-induced cardiac dysfunction and apoptosis. Am J Physiol Heart Circ Physiol. 2002;283:H688-H694.
11. Melo LG, Agrawal R, Zhang L, et al. Gene therapy strategy for long-term myocardial protection using adeno-associated virus-mediated delivery of heme oxygenase gene. Circulation. 2001;104:r4O-r45.
12. Nakamura K, Fushimi K, Kouchi H, et al. Inhibitory effects of anti-oxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-α and angiotensin II. Circulation. 1998;98:794-799.
13. phox-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation. 2002;105:293-296.
14. Nakagami H, Takemoto M, Liao K. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy. J Mol Cell Cardiol. 2003;35:851-859.
15. Simpson P, Savion S. Differentiation of rat myocytes in single cell culture with and without proliferating nonmyocardial cells. Circ Res. 1982;50:101-116.
16. Juan S-H, Lee T-S, Tseng K-W, et al. Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2001;104:1519-1525.
17. Turcanu V, Dhouib M, Poindron P. Determination of heme oxygenase activity in murine macrophages for studying oxidative stress inhibitors. Anal Biochem. 1998;263:251-253.
18. Dolber PC, Beyer EC, Junker JL, et al. Distribution of gap junctions in dog and rat ventricle studies with a double-label technique. J Mol Cell Cardiol. 1992;24:1443-1457.
19. Mottelini R, Clark JE, Forest R, et al. Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res. 2002;90:E17-E24.
20. Kodama H, Fukuda K, Pan J, et al. Leukemia inhibitory factor, a potent cardiac hypertrophic cytokine, activates the JAK/STAT pathway in rat cardiomyocytes. Circ Res. 1997;81:656-663.
21. Ishizaka N, Aizawa T, Mori I, et al. Heme oxygenase-1 is upregulated in the rat heart in response to chronic administration of angiotensin II. Am J Physiol Heart Circ Physiol. 2000;279:H672-H678.
22. Levere RD, Martasek P, Escalante B, et al. Effect of heme arginate administration on blood pressure in spontaneous hypertensive rats. J Clin Invest. 1990;86:213-219.
23. Johnson RA, Lavesa M, DeSeyn K, et al. Heme oxygenase substrates acutely lower blood pressure in hypertensive rats. Am J Physiol Heart Circ Physiol. 1996;40:H1132-H1138.
24. Motterlini R, Gonzales A, Foresti R, et al. Heme oxygenase-1-derived carbon monoxide contributes to the suppression of acute hypertensive responses in vivo. Circ Res. 1998;83:568-577.
25. dos Santos EA, Yamaguishi GA, Heimaun JC. Effect of the heme/heme oxygenase pathway on the relationship between salt consumption and blood pressure. J Hypertens. 1998;16:1965-1969.
26. Ndisang JF, Zhao W, Wang R. Selective regulation of blood pressure by heme oxygenase-1 in hypertension. Hypertension. 2002;40:315-321.
27. Imai T, Morita T, Shindo T, et al. Vascular smooth muscle cell-directed overexpression of heme oxygenase-1 elevates blood pressure through attenuation of nitric oxide-induced vasodilation in mice. Circ Res. 2001;89:55-62.
28. Seki T, Naruse M, Naruse K, et al. Induction of heme oxygenase produces load-independent cardioprotective effects in hypertensive rats. Life Sci. 1999;65:1077-1086.
29. Hopkins PN, Wu LL, Hunt SS, et al. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol. 1996;16:250-255.
30. Djousse L, Levy D, Cupples LA, et al. Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol. 2001;87:1196-1200.
31. Greabu M, Olinescu R, Kummerow FA, et al. The levels of bilirubin may be related to an inflammatory condition in patients with coronary heart disease. Acta Pol Pharm. 2001;58:225-231.
32. Sato K, Balla J, Otterbein L, et al. Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to rat cardiac transplants. J Immunol. 2001;166:4185-4194.
33. Platt JL, Nath KA. Heme oxygenase: protective gene or Trojan horse. Nat Med. 1998;12:1364-1365.
34. Sawyer DB, Siwik DA, Xiao L, et al. Role of oxidative stress in myocardial hypertrophy and failure. J Mol Cell Cardiol. 2002;34:379-388.